Premium
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
Author(s) -
Adler Charles H.,
Factor Stewart A.,
Brin Mitchell,
Sethi Kapil D.
Publication year - 2002
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.10001
Subject(s) - medicine , dystonia , botulinum toxin , blepharospasm , dermatology , surgery , psychiatry
Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6‐year period. © 2002 Movement Disorder Society.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom